Model for end-stage liver disease (MELD) exception... : Liver Transplantation (original) (raw)

Supplement Articles

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

Freeman, Richard B. Jr.1; Gish, Robert G.2; Harper, Ann3; Davis, Gary L.4; Vierling, John5; Lieblein, Leslie3; Klintmalm, Goran4; Blazek, Jamie6; Hunter, Robert3; Punch, Jeffrey7

1_Division of Transplantation, Department of Surgery, Tufts–New England Medical Center, Boston, MA_

2_Departments of Medicine and Transplantation and the Division of Hepatology and Complex GI, Physicians Foundation, California Pacific Medical Center, San Francisco, CA_

3_United Network for Organ Sharing, Richmond, VA_

4_Baylor Regional Transplant Institute, Baylor University Medical Center, Dallas, TX_

5_Department of Medicine, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA_

6_Ochsner Multi-Organ Transplant Center, New Orleans, LA_

7_Department of Surgery, University of Michigan, Ann Arbor, MI_

Address reprint requests to Richard B. Freeman, Jr., MD, Division of Transplant Surgery, Tufts-New England Medical Center, Box 40, 750 Washington Street, Boston, MA 02111

Address reprint requests to Robert G. Gish, MD, 2340 Clay Street, Room 223, California Pacific Medical Center, San Francisco, CA 94115

Email: [email protected]

Published online in Wiley InterScience (www.interscience.wiley.com).

Telephone: 617-636-5592; FAX: 617-636-8228

Telephone: 415-600-1020 or -1022; FAX: 415-776-0292